ATRO Medical raises €3.0M Series A round
24 February 2026· Nijmegen, Netherlands· health, medical_devices, materials, b2b, deep_hardware
The funding will be used to advance the Artimis Meniscus Prosthesis toward pivotal clinical trials in the United States and Europe, expand clinical evidence, and support manufacturing optimization and regulatory readiness.
Investors
Lead819 Capital
Also participating
Thuja CapitalBolwork International InvestmentDSM-Firmenich VenturesSamaplast
About ATRO Medical
Headquarters
Nijmegen, Netherlands
Founded
2016
Team Size
6–20
Sectors
healthmedical_devicesmaterialsb2bdeep_hardware